Contact Us

HOTEL NEWS

CGTN AMERICA & CCTV UN: Chinese Films Gain Ground at 45th American Film Market

Nov 13, 2024

WASHINGTON,Nov. 13,2024-- CGTN America & CCTV UN releases "Chinese Films Gain Ground at 45th American Film Market."

Samyang Corporation Achieves First Novel Food Approval for Allulose in Australia and New Zealand

Nov 13, 2024

Receives Novel Food approval from Food Standards Australia New Zealand (FSANZ) Recognized as an official low-calorie sweetener for use in sugar-reduced and sugar-free products

YCH Group Partners with Vietnamese Government to Propel SMEs onto the Global Stage

Nov 13, 2024

SINGAPORE,Nov. 13,2024-- In a significant move to strengthen Vietnam\'s presence in international markets,the country\'s Minister of Information and Communications,Nguyen Manh Hung,has invited Singap

Thai Language Courses for Foreign Nationals at Chula

Nov 13, 2024

BANGKOK,Nov. 13,2024-- "Learning Thai language can open the door to new experiences and employment opportunities for foreigners living or traveling in Thailand," said Assistant Professor Dr.

BLUETTI Unveils Elite 200 Portable Power Station Promising Over 17 Years of Dependable Charging

Nov 13, 2024

LAS VEGAS,Nov. 13,2024-- BLUETTI,a leader in portable power stations and eco-friendly energy solutions,launches the Elite 200 V2,a 2KWh all-powerful portable power station designed for easy and conve

A Phase I/II Clinical Study of Anti-HER2 Bispecific ADC Subcutaneous Co-formulation JSKN033 was Included in the Pilot Program for Optimizing the Review and Approval of Clinical Trials for Innovative Drugs

Nov 13, 2024

SUZHOU,China,Nov. 13,2024-- Alphamab Oncology (stock code: 9966.HK) announced that a clinical trial (Study ID: JSKN033-102) of JSKN033,a high-concentration subcutaneous co-formulation consisting of an

1 ... 206 207 208 209 210 211 212 ... 328